Effects of monitoring strategies on seizures in pregnant women on lamotrigine: A meta-analysis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 172, Issue 1, 2014, Pages 26-31

  Pirie, Dulcie A J ^a   Wattar, Bassel H Al ^b   Pirie, Alexander M ^b,c   Houston, Victoria ^c   Siddiqua, Ayesha ^c   Doug, Manjo ^b   Bagary, Manny ^e   Greenhill, Lyn ^e   Khan, Khalid S ^d   McCorry, Dougall ^f   Thangaratinam, Shakila ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti epileptic drugs; Epilepsy; Lamotrigine; Monitoring; Pregnancy

Indexed keywords

LAMOTRIGINE;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURES MONITORING; CONGENITAL DISORDER; DATA EXTRACTION; DETERIORATION; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; FETUS OUTCOME; HUMAN; HYDRONEPHROSIS; META ANALYSIS; MONITORING; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY CONTROL; SEIZURE; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTI-EPILEPTIC DRUGS; EPILEPSY; LAMOTRIGINE; MONITORING; PREGNANCY;

ANTICONVULSANTS; DRUG MONITORING; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; TRIAZINES;

EID: 84891835127     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.10.021     Document Type: Article

References (21)

1. N. Adab, U. Kini, and J. Vinten et al. The longer term outcome of children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 75 2004 1575 1583
2. Confidential enquiry into maternal and child health. Why mothers die The sixth report of the confidential enquiry into maternal deaths in the United Kingdom. RCOG 2004 2000-2002
3. N. Schupf, and R. Ottman Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for spontaneous abortion Epilepsia 38 1997 824 829
4. N. Schupf, and R. Ottman Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for reduced fertility in marriage Epilepsia 37 1996 833 840
5. N. Schupf, and R. Ottman Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences Epilepsia 35 1994 750 756
6. N. Adab, U. Kini, and J. Vinten et al. The longer term outcome of children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 75 2004 1575 1583
7. N. Adab, and D.W. Chadwick Management of women with epilepsy during pregnancy Obstet Gynaecol 8 2006 20 25
8. Practice parameter: management issues for women with epilepsy (summary statement) Report of the Quality Standard Subcommittee of the American Academy of Neurology October 1 1998
9. Scottish Intercollegiate Guidelines Network 70 Diagnosis and management of epilepsy in adults 1993 A National Clinical Guideline
10. G.J. de Haan, P. Edelbroek, and J. Segers et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study Neurology 63 2004 571 573
11. I. Ohman, O. Beck, S. Vitols, and T. Tomson Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy Epilepsia 49 2008 1075 1080
12. P.B. Pennell Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency Neurology 70 2008 2130 2136
13. V. Petrenaite, A. Sabers, and J. Hansen-Schwartz Individual changes in lamotrigine plasma concentrations during pregnancy Epilepsy Res 65 2005 185 188
14. T.A. Tran, I.E. Leppik, K. Blesi, S.T. Sathanandan, and R. Remmel Lamotrigine clearance during pregnancy Neurology 59 2002 251 255
15. N. Adab Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? CNS Drugs 20 2006 791 800
16. P.B. Pennell Antiepileptic drug pharmacokinetics during pregnancy and lactation Neurology 61 6 Suppl. 2 2003 S35 S42
17. P.B. Pennell, and C.A. Hovinga Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics Int Rev Neurobiol 83 2008 227 240
18. A.G. Marson, A.M. Al Kharusi, and M. Alwaidh On behalf of the SANAD study group Study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1000 1015
19. S. Miskov, R. Gjergja-Juraski, and L. Cvitanovic-Sojat et al. Prospective surveillance of Croatian pregnant women on lamotrigine monotherapy - aspects of pre-pregnancy counseling and drug monitoring Acta Clin Croatica 48 2009 271 281
20. National Collaborating Centre for Primary Care The diagnosis and management of the epilepsies in adults and children in primary and secondary care 2012 http://www nice org uk/nicemedia/pdf/CG020fullguideline pdf [accessed 02.08.13]
21. P.N. Patsalos, D.J. Berry, and B.F. Bourgeois et al. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies Epilepsia 49 2008 1239 1276